---
title: ENL 2017 Genetic Risk Classification
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[acute myelogenous leukemia (AML)]]

## ENL 2017 Genetic Risk Classification
Â (BloodÂ 2017;129:424)

## Favorable ðŸŸ¢

* APL: t(15;17);Â PML-RARa;

* t(8;21):Â RUNX1-RUNX1T1; inv(16):Â CBFB-MYH1;

* mutatedÂ NPM1Â w/o FLT3-ITD or w/ FLT3-ITDlow*;

* biallelic mutation inÂ CEBPA

## Intermediate ðŸŸ¡

* FLT3-ITDlow*; mutatedÂ NPM1 &Â FLT3-ITDhigh*; t(9;11):Â MLL-MLLT3;

* cytogenetic abnl not classified as favorable or adverse, including normal karyotype w/o mutations inÂ FLT3-ITDÂ &Â NPM1

## Adverse ðŸ”´

* -5 or del(5q); -7; -17/abn(17p); complex or monosomal karyotype;

* t(6;9):Â DEK-NUP214; t(9;22)Â BCR-ABL1; inv(3):Â GATA2-MECOM;

* wildtypeÂ NPM1 &Â FLT-ITDhigh*; mutatedÂ TP53, RUNX1, ASXL1


---

* low/high:Â FLT3-ITDÂ variant allele frequency (VAF); reflects burden of mut. leukemic cells

